Mesenchymal Stem Cells (MSCs) for Acute Lung Injury

MSCs for Acute Lung Injury. Several experimental studies published by NIH on February 16, 2023, have suggested that mesenchymal stem cells may hold value for treating clinical disorders, including myocardial infarction, diabetes, acute kidney injury, sepsis, and acute lung injury. In preclinical studies, mesenchymal stem cells have been effective in reducing lung damage caused by […]